Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014
- Corporate Author:
- United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health
- Washington : U.S. Government Publishing Office, 2015.
- Physical Description:
- 1 online resource (iv, 217 pages)
- Title from title screen (viewed on July 24, 2015).
Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
"Serial No. 113-147."
- Bibliography Note:
- Includes bibliographical references.
View MARC record | catkey: 15750588